| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cell, Tumor, and Stem Cell Biology |
1 Molecular Biology Unit, Department of Experimental Oncology, Fondazione Istituti di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milano, Italy and 2 Department of Molecular Virology, Immunology and Medical Genetics and Comprehensive Cancer Center, Ohio State University, Columbus, Ohio
Requests for reprints: Carlo M. Croce, Department of Molecular Virology, Immunology and Medical Genetics and Comprehensive Cancer Center, Ohio State University, Room 445C, Wiseman Hall, 400 12th Avenue, Columbus, OH 43210. Phone: 614-292-3063; Fax: 614-292-3312; E-mail: Carlo.Croce{at}osumc.edu.
Epithelial ovarian cancer (EOC) is the sixth most common cancer in women worldwide and, despite advances in detection and therapies, it still represents the most lethal gynecologic malignancy in the industrialized countries. Unfortunately, still relatively little is known about the molecular events that lead to the development of this highly aggressive disease. The relatively recent discovery of microRNAs (miRNA), a class of small noncoding RNAs targeting multiple mRNAs and triggering translation repression and/or RNA degradation, has revealed the existence of a new level of gene expression regulation. Multiple studies involving various types of human cancers proved that miRNAs have a causal role in tumorigenesis. Here we show that, in comparison to normal ovary, miRNAs are aberrantly expressed in human ovarian cancer. The overall miRNA expression could clearly separate normal versus cancer tissues. The most significantly overexpressed miRNAs were miR-200a, miR-141, miR-200c, and miR-200b, whereas miR-199a, miR-140, miR-145, and miR-125b1 were among the most down-modulated miRNAs. We could also identify miRNAs whose expression was correlated with specific ovarian cancer biopathologic features, such as histotype, lymphovascular and organ invasion, and involvement of ovarian surface. Moreover, the levels of miR-21, miR-203, and miR-205, up-modulated in ovarian carcinomas compared with normal tissues, were significantly increased after 5-aza-2'-deoxycytidine demethylating treatment of OVCAR3 cells, suggesting that the DNA hypomethylation could be the mechanism responsible for their overexpression. Our results indicate that miRNAs might play a role in the pathogenesis of human EOC and identify altered miRNA gene methylation as a possible epigenetic mechanism involved in their aberrant expression. [Cancer Res 2007;67(18):8699–707]
This article has been cited by other articles:
![]() |
S. V. Naga Prasad, Z.-H. Duan, M. K. Gupta, V. S. K. Surampudi, S. Volinia, G. A. Calin, C.-G. Liu, A. Kotwal, C. S. Moravec, R. C. Starling, et al. Unique MicroRNA Profile in End-stage Heart Failure Indicates Alterations in Specific Cardiovascular Signaling Networks J. Biol. Chem., October 2, 2009; 284(40): 27487 - 27499. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Edson, A. K. Nagaraja, and M. M. Matzuk The Mammalian Ovary from Genesis to Revelation Endocr. Rev., October 1, 2009; 30(6): 624 - 712. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.O. Burney, A.E. Hamilton, L. Aghajanova, K.C. Vo, C.N. Nezhat, B.A. Lessey, and L.C. Giudice MicroRNA expression profiling of eutopic secretory endometrium in women with versus without endometriosis Mol. Hum. Reprod., October 1, 2009; 15(10): 625 - 631. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. C. Ohlsson Teague, C. G. Print, and M. L. Hull The role of microRNAs in endometriosis and associated reproductive conditions Hum. Reprod. Update, September 22, 2009; (2009) dmp034v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yang, J. Gu, K. K. Wang, W. Zhang, J. Xing, Z. Chen, J. A. Ajani, and X. Wu MicroRNA Expression Signatures in Barrett's Esophagus and Esophageal Adenocarcinoma Clin. Cancer Res., September 15, 2009; 15(18): 5744 - 5752. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Balch, F. Fang, D. E. Matei, T. H.-M. Huang, and K. P. Nephew Minireview: Epigenetic Changes in Ovarian Cancer Endocrinology, September 1, 2009; 150(9): 4003 - 4011. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Park, H. Zhou, D. Elashoff, B. S. Henson, D. A. Kastratovic, E. Abemayor, and D. T. Wong Salivary microRNA: Discovery, Characterization, and Clinical Utility for Oral Cancer Detection Clin. Cancer Res., September 1, 2009; 15(17): 5473 - 5477. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, R. Rathinam, A. Walch, and S. K. Alahari ST14 (Suppression of Tumorigenicity 14) Gene Is a Target for miR-27b, and the Inhibitory Effect of ST14 on Cell Growth Is Independent of miR-27b Regulation J. Biol. Chem., August 21, 2009; 284(34): 23094 - 23106. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Y. F. Lee, P. S. Rennie, and W. W.G. Jia MicroRNA Regulation of Oncolytic Herpes Simplex Virus-1 for Selective Killing of Prostate Cancer Cells Clin. Cancer Res., August 15, 2009; 15(16): 5126 - 5135. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Sotiropoulou, G. Pampalakis, E. Lianidou, and Z. Mourelatos Emerging roles of microRNAs as molecular switches in the integrated circuit of the cancer cell RNA, August 1, 2009; 15(8): 1443 - 1461. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Seike, A. Goto, T. Okano, E. D. Bowman, A. J. Schetter, I. Horikawa, E. A. Mathe, J. Jen, P. Yang, H. Sugimura, et al. MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers PNAS, July 21, 2009; 106(29): 12085 - 12090. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Pandey and D. Picard miR-22 Inhibits Estrogen Signaling by Directly Targeting the Estrogen Receptor {alpha} mRNA Mol. Cell. Biol., July 1, 2009; 29(13): 3783 - 3790. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Bannister, M. L.V. Tizard, T. J. Doran, A. H. Sinclair, and C. A. Smith Sexually Dimorphic MicroRNA Expression During Chicken Embryonic Gonadal Development Biol Reprod, July 1, 2009; 81(1): 165 - 176. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Yamamichi, R. Shimomura, K.-i. Inada, K. Sakurai, T. Haraguchi, Y. Ozaki, S. Fujita, T. Mizutani, C. Furukawa, M. Fujishiro, et al. Locked Nucleic Acid In situ Hybridization Analysis of miR-21 Expression during Colorectal Cancer Development Clin. Cancer Res., June 15, 2009; 15(12): 4009 - 4016. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Huse, C. Brennan, D. Hambardzumyan, B. Wee, J. Pena, S. H. Rouhanifard, C. Sohn-Lee, C. le Sage, R. Agami, T. Tuschl, et al. The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo Genes & Dev., June 1, 2009; 23(11): 1327 - 1337. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Lebanony, H. Benjamin, S. Gilad, M. Ezagouri, A. Dov, K. Ashkenazi, N. Gefen, S. Izraeli, G. Rechavi, H. Pass, et al. Diagnostic Assay Based on hsa-miR-205 Expression Distinguishes Squamous From Nonsquamous Non-Small-Cell Lung Carcinoma J. Clin. Oncol., April 20, 2009; 27(12): 2030 - 2037. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Avissar, B. C. Christensen, K. T. Kelsey, and C. J. Marsit MicroRNA Expression Ratio Is Predictive of Head and Neck Squamous Cell Carcinoma Clin. Cancer Res., April 15, 2009; 15(8): 2850 - 2855. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T.N. Le, C. Teh, N. Shyh-Chang, H. Xie, B. Zhou, V. Korzh, H. F. Lodish, and B. Lim MicroRNA-125b is a novel negative regulator of p53 Genes & Dev., April 1, 2009; 23(7): 862 - 876. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Visone and C. M. Croce MiRNAs and Cancer Am. J. Pathol., April 1, 2009; 174(4): 1131 - 1138. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Z. Carletti and L. K. Christenson MicroRNA in the ovary and female reproductive tract J Anim Sci, April 1, 2009; 87(14_suppl): E29 - E38. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Gandellini, M. Folini, N. Longoni, M. Pennati, M. Binda, M. Colecchia, R. Salvioni, R. Supino, R. Moretti, P. Limonta, et al. miR-205 Exerts Tumor-Suppressive Functions in Human Prostate through Down-regulation of Protein Kinase C{varepsilon} Cancer Res., March 15, 2009; 69(6): 2287 - 2295. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. V. Iorio, P. Casalini, C. Piovan, G. Di Leva, A. Merlo, T. Triulzi, S. Menard, C. M. Croce, and E. Tagliabue microRNA-205 Regulates HER3 in Human Breast Cancer Cancer Res., March 15, 2009; 69(6): 2195 - 2200. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hiyoshi, H. Kamohara, R. Karashima, N. Sato, Y. Imamura, Y. Nagai, N. Yoshida, E. Toyama, N. Hayashi, M. Watanabe, et al. MicroRNA-21 Regulates the Proliferation and Invasion in Esophageal Squamous Cell Carcinoma Clin. Cancer Res., March 15, 2009; 15(6): 1915 - 1922. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Mascaux, J. F. Laes, G. Anthoine, A. Haller, V. Ninane, A. Burny, and J. P. Sculier Evolution of microRNA expression during human bronchial squamous carcinogenesis Eur. Respir. J., February 1, 2009; 33(2): 352 - 359. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Sarkar, R. Parkin, S. Wyman, A. Bendoraite, C. Sather, J. Delrow, A. K. Godwin, C. Drescher, W. Huber, R. Gentleman, et al. Quality Assessment and Data Analysis for microRNA Expression Arrays Nucleic Acids Res., February 1, 2009; 37(2): e17 - e17. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Su, J.-R. Yang, T. Xu, J. Huang, L. Xu, Y. Yuan, and S.-M. Zhuang MicroRNA-101, Down-regulated in Hepatocellular Carcinoma, Promotes Apoptosis and Suppresses Tumorigenicity Cancer Res., February 1, 2009; 69(3): 1135 - 1142. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-B. Lee, I. Bantounas, D.-Y. Lee, L. Phylactou, M. A. Caldwell, and J. B. Uney Twist-1 regulates the miR-199a/214 cluster during development Nucleic Acids Res., January 1, 2009; 37(1): 123 - 128. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Mayoral, M. E. Pipkin, M. Pachkov, E. van Nimwegen, A. Rao, and S. Monticelli MicroRNA-221-222 Regulate the Cell Cycle in Mast Cells J. Immunol., January 1, 2009; 182(1): 433 - 445. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Taccioli, E. Fabbri, R. Visone, S. Volinia, G. A. Calin, L. Y. Fong, R. Gambari, A. Bottoni, M. Acunzo, J. Hagan, et al. UCbase & miRfunc: a database of ultraconserved sequences and microRNA function Nucleic Acids Res., January 1, 2009; 37(suppl_1): D41 - D48. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Yang, S. Kaur, S. Volinia, J. Greshock, H. Lassus, K. Hasegawa, S. Liang, A. Leminen, S. Deng, L. Smith, et al. MicroRNA Microarray Identifies Let-7i as a Novel Biomarker and Therapeutic Target in Human Epithelial Ovarian Cancer Cancer Res., December 15, 2008; 68(24): 10307 - 10314. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yu, D. G. Ryan, S. Getsios, M. Oliveira-Fernandes, A. Fatima, and R. M. Lavker MicroRNA-184 antagonizes microRNA-205 to maintain SHIP2 levels in epithelia PNAS, December 9, 2008; 105(49): 19300 - 19305. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Bearfoot, D. Y.H. Choong, K. L. Gorringe, and I. G. Campbell Genetic Analysis of Cancer-Implicated MicroRNA in Ovarian Cancer Clin. Cancer Res., November 15, 2008; 14(22): 7246 - 7250. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-J. Hu, G. Ren, J.-L. Liu, Z.-A. Zhao, Y.-S. Yu, R.-W. Su, X.-H. Ma, H. Ni, W. Lei, and Z.-M. Yang MicroRNA Expression and Regulation in Mouse Uterus during Embryo Implantation J. Biol. Chem., August 22, 2008; 283(34): 23473 - 23484. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kim, U. J. Lee, M. N. Kim, E.-J. Lee, J. Y. Kim, M. Y. Lee, S. Choung, Y. J. Kim, and Y.-C. Choi MicroRNA miR-199a* Regulates the MET Proto-oncogene and the Downstream Extracellular Signal-regulated Kinase 2 (ERK2) J. Biol. Chem., June 27, 2008; 283(26): 18158 - 18166. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhang, S. Volinia, T. Bonome, G. A. Calin, J. Greshock, N. Yang, C.-G. Liu, A. Giannakakis, P. Alexiou, K. Hasegawa, et al. Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer PNAS, May 13, 2008; 105(19): 7004 - 7009. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Nam, H. Yoon, S. W. Kim, H. Kim, Y. T. Kim, J. H. Kim, J. W. Kim, and S. Kim MicroRNA Expression Profiles in Serous Ovarian Carcinoma Clin. Cancer Res., May 1, 2008; 14(9): 2690 - 2695. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |